Physician profile
George Isaac
NPI 1588652416
$5,481.48
in general payments reported to CMS, 2019-2025
22 companies · $611 in 2025
The $611 reported for 2025 was more than what 82% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $891 · 2020: $699 · 2021: $848 · 2022: $1,091 · 2023: $649 · 2024: $693 · 2025: $611.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,953.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,952.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,774.36 | 2019-2025 | Tavneos, Enbrel, Evenity |
| Janssen Biotech, INC. | $580.95 | 2019-2025 | Tremfya, Simponi Aria, Remicade |
| Ucb, INC. | $565.30 | 2019-2025 | Cimzia, Bimzelx |
| Pfizer INC. | $487.02 | 2019-2025 | |
| Abbvie INC. | $454.67 | 2019-2025 | |
| Horizon Therapeutics Plc | $353.90 | 2019-2023 | Krystexxa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $250.44 | 2019-2024 | Ofev, Cyltezo |
| Mallinckrodt Hospital Products INC. | $164.03 | 2021-2025 | Acthar |
| Lilly USA, LLC | $140.95 | 2019-2021 | |
| Radius Health, INC. | $128.67 | 2019-2025 | Tymlos |
| E.R. Squibb & Sons, L.L.C. | $111.38 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $91.11 | 2020-2025 | |
| Genzyme Corporation | $59.37 | 2019 | |
| Genentech USA, INC. | $58.59 | 2019-2024 | Actemra |
| Astrazeneca Pharmaceuticals LP | $53.33 | 2022-2024 | Saphnelo |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $47.85 | 2019-2022 | |
| Glaxosmithkline, LLC. | $43.36 | 2022 | |
| Organon LLC | $39.57 | 2024 | |
| Ani Pharmaceuticals, INC. | $21.48 | 2025 | Purified Cortrophin Gel |
| Actelion Pharmaceuticals US, INC. | $19.89 | 2023 | Opsumit, Uptravi |
| Ferring Pharmaceuticals INC. | $19.26 | 2022 | |
| Almatica Pharma LLC | $16.00 | 2024 | Teriparatide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Isaac listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.